Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire, UK; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome ...

A new study led by investigators from Newcastle University and the Wellcome Sanger Institute is aiming to reveal disease biomarkers in inflammatory bowel disease (IBD) and identify new and ...

INDIANAPOLIS, Aug. 14, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) is launching an open innovation challenge to encourage individuals and teams across the U.S. to identify and submit ...

Please provide your email address to receive an email when new articles are posted on . Therapeutic “de-escalation” relies on analysis of disease-related factors and careful monitoring of pediatric ...